Evicenter
P&T meetings

Tovecimig (CTX-009)

Second-line advanced biliary tract cancer

Also known as ABL001
Last updated
89 sources

Economic information and modeling reportBudget impact model

Approach and framework

1 evidence topic · 3 sources

Budget impact model of tovecimig: approach and framework

No evidence found.

Model structures used in economic evaluations of advanced biliary tract cancer

“The progression-free health state was further divided into on-treatment and off-treatment substates. The EAG agreed that the structure of the economic model was appropriate and consistent with previous NICE evaluations for biliary tract cancer.” (opens the source at this quote in a new tab)

“In comparing medical costs and clinical outcomes between patients with BTC treated with pembrolizumab plus chemotherapy and those treated with chemotherapy, we used a partitioned survival model” (opens the source at this quote in a new tab)

“The health states included in this model were PFS, progressed disease (PD), and death.” (opens the source at this quote in a new tab)

“The model included three health states: PFS, progressive disease (PD) and death.” (opens the source at this quote in a new tab)